Methods and compositions for treating an angiotensinogen(AGT-) associated disorder
PH12022551158B1Active Publication Date: 2026-11-06ALNYLAM PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12022551158
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-05-12
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2042-05-12
Abstract
The present invention relates to methods of inhibiting the expression of an AGT gene in a subject, as well as methods for treating subjects having an AGTassociated disorder, e.g., hypertension, using RNAi agents, e.g., double stranded RNAi agents, targeting the AGT gene. The invention also relates to methods of decreasing blood pressure levels in a subject using such RNAi agents to inhibit expression of an AGT gene.
Need to check novelty before this filing date? Find Prior Art
